Adults 18 to 40, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Center of PressurePrimary· 10 minutes of 2 hours
Indicator for the balance of the study participants. This outcome was measured using a force plate, in which the anteroposterior and mediolateral directions of the center of pressure are recorded. The center of pressure is a visual projection of the center of mass of the participant. For the anteroposterior direction of the center of pressure, a positive value \[mm\] represents the anterior direction and a negative value \[mm\] represents the posterior direction. For the mediolateral direction of the center of pressure, a positive value \[mm\] represents the right-lateral direction and a negat
Experimental conditions without exoskeleton
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
-42.76
-48.19 – -25.55
First With Exoskeleton and Then Without Exoskeleton
-34.98
-49.16 – -22.18
Experimental conditions with exoskeleton
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
-118.34
-128.42 – -107.43
First With Exoskeleton and Then Without Exoskeleton
-122.16
-130.80 – -111.58
Muscle Activity of the Lower Back (M. Erector Spinae Lumbalis)Primary· 10 minutes of 2 hours
Indicator for the muscular load in the lower back (M. erector spinae lumbalis) that may change when wearing the passive exoskeleton.
The muscle activity was recorded using bipolar surface electromyography, during which two electrodes are placed on the muscle belly. The absolute value of muscle activity recordings is in microvolt, but since this is difficult to interpret, we have normalized this to a reference voluntary contraction that was executed by each participant prior to the experiment. The unit of measure for normalized muscle activity therefore is a percentage, i.e. a percentage of th
Experimental conditions without the exoskeleton
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
11.02
7.06 – 13.89
First With Exoskeleton and Then Without the Exoskeleton
7.78
6.62 – 11.70
Experimental conditions with the exoskeleton
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
6.80
5.39 – 11.11
First With Exoskeleton and Then Without the Exoskeleton
8.29
4.58 – 11.44
Back Posture: Upper Back Forward Flexion Angle With Respect to the Perpendicular (Earth)Secondary· 10 minutes of 2 hours
The posture of the back may indicate whether the relative body posture changed when wearing the passive exoskeleton compared to not wearing the passive exoskeleton.
In the current study, back posture was recorded using two gravimetric position sensors placed on the thoracic vertebrae T3 and lumbal vertebrae L3.
The difference between both position sensors represented the trunk forward flexion angle \[°\].
Experimental conditions without the exoskeleton
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
11.55
4.83 – 17.10
First With Exoskeleton Then Without Exoskeleton
5.10
-3.31 – 10.83
Experimental conditions with the exoskeleton
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
25.00
14.89 – 36.85
First With Exoskeleton Then Without Exoskeleton
20.95
12.30 – 31.08
Subjective Feeling of Overall DiscomfortSecondary· 10 minutes of 2 hours
Indicate whether participants develop feelings of discomfort in different experimental conditions when wearing or not wearing the passive exoskeleton.
Discomfort was recorded using an 11-point numeric rating scale, running from 0 (no discomfort at all) to 10 (maximally imaginable discomfort).
So, the outocme is in \[units on a scale from 0 to 10\].
Experimental conditions without the exoskeleton
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
0
0 – 0
First With Exoskeleton Then Without Exoskeleton
0
0 – 1.25
Experimental conditions with the exoskeleton
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
2
0 – 2
First With Exoskeleton Then Without Exoskeleton
0
0 – 2
Participant EvaluationSecondary· 2 hours
A questionnaire indicating whether wearing the passive exoskeleton during simluated assembly tasks is evaluated as comfortable, feasible, and usable.
Below, the 10 statements questions as part of the participant evaluation questionnaire are shown with an interpretation of the score.
1 generally reflects "I do not agree at all" whereas 10 generally reflects "I fully agree".
Depending on the question, a score closer or equal to 1 is better and 10 worse, or vice versa.
Statements 1-8: a higher score (i.e., close to 10) is considered better Statements 9-10: a lower score (i.e., close to 1) is
The exoskeleton was comfortable
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
6.4
± 2.1
First With Exoskeleton Then Without
6.9
± 1.9
The exoskeleton was easy to operate / handle
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
8.4
± 1.4
First With Exoskeleton Then Without
8.7
± 1.3
I was able to work precisely with the exoskeleton
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
9.1
± 1.1
First With Exoskeleton Then Without
8.7
± 1.3
The exoskeleton is suitable for the simulated task
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
8.3
± 1.8
First With Exoskeleton Then Without
8.1
± 1.6
I can imagine working with the exoskeleton longer
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
7.4
± 2.2
First With Exoskeleton Then Without
6.9
± 2.1
The working posture was comfortable in high sit
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
5.9
± 2.0
First With Exoskeleton Then Without
5.1
± 2.0
The working posture was comfortable in low sit
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
6.9
± 2.2
First With Exoskeleton Then Without
7.2
± 1.7
I felt safe to use the exoskeleton in high sit
Group
Value
95% CI
First Without Exoskeleton Then With Exoskeleton
7.5
± 2.1
First With Exoskeleton Then Without
6.6
± 2.1
Sponsor's own description
Standing work is associated with increased risks of venous and musculoskeletal disorders; particularly low back pain is commonly reported in prolonged standing work. In manufacturing work, workstations often do not allow standing aids due to insufficient functional and spatial conditions. In 2014, the car manufacturer Audi introduced the lower leg exoskeleton developed by Noonee to their employees working in the factories. This exoskeleton, the 'Chairless Chair' has the advantage that standing work can be performed while technically sitting on this device. The exoskeleton offers the potential for reduced awkward body postures, but it is unclear which physiological and biomechanical loads are influenced and how. This proposal provides a study design evaluating the 'Chairless Chair' in a laboratory setting, by testing its effectiveness in terms of physiological and biomechanical parameters. It is suggested to compare different assembly tasks while wearing the exoskeleton, compared with not wearing the exoskeleton. The 'Chairless Chair' is developed in one size only, which is why we propose to include participants of different body height, which will enable us to investigate whether body height influences the effectiveness of wearing the device.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT06707207 — Predicting Future Errors During Skill Performance
· recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
· Phase 1
· recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease.
· NA
· recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects
· NA
· recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity
· Phase 1, PHASE2
· recruiting
Other University Hospital Tuebingen trials
Trials by the same sponsor.
NCT07378670 — DEfeating PEnile CAncer-2
· NA
· recruiting
NCT07276503 — Verification of a New Predictive Delirium Score in Adults With Elective Cardiac Valve or Bypass Surgery With Perioperati
· not yet recruiting
NCT07411365 — Dual-task Cognitive-motor Telerehabilitation in Persons With PD-MCI
· NA
· not yet recruiting
NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat
· Phase 2
· recruiting
NCT07378891 — Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI)
· enrolling by invitation
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Tuebingen
Last refreshed: 16 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03134144.